Kiora Pharmaceuticals publishes phase 1 retinitis pigmentosa study data

April 14, 2026 7:02 AM

Kiora Pharmaceuticals (NASDAQ: KPRX) announced the publication of its Phase 1 ABACUS-1 study results for KIO-301 in Nature Medicine. The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found